 |
Dr. Nathan Davis' Publications |
 |
1. Davis N, Bargmann W, Lim M-Y, Bose HR, Jr. Avian Reticuloendotheliosis virus-transformed lymphoid cells contain multiple pp59v-rel complexes. J Virol 64:584-591, 1990.
2. Lim M-Y, Davis N, Zhang J, Bose HR, Jr. The v-rel oncogene product is complexed with cellular proteins including its proto-oncogene product and heat shock protein 70. Virology 175:149-160, 1990.
3. Davis JN, Bargmann W, Bose HR, Jr. Identification of protein complexes containing the c-rel proto-oncogene product in avian hematopoetic cells. Oncogene 5:1109-1115, 1990.
4. Kerr LD, Inoue J-I, Davis N, Link E, Bauerle PA, Bose HR Jr, Verma I. The rel-associated pp40 protein prevents DNA binding of REL and NF-kB: Relationship with IkB and regulation by phosphorylation. Genes Devel 5:1464-1476, 1991.
5. Davis N, Ghosh S, Simmons D, Tempst P, Liou H-C, Baltimore D, Bose HR Jr. Rel-associated pp40: An inhibitor of the rel family of transcription factors. Science 253:1268-1271, 1991.
6. Inoue J-I, Kerr LD, Rashid, Davis N, Bose HR Jr., Verma IM. Direct association of pp40/IkB with rel/NF-kB proteins: Role of ankyrin repeats in the inhibition of DNA binding activity. Proc Natl Acad Sci USA 89:4333-4337, 1992.
7. Roussel MF, Davis JN, Cleveland JL, Ghysdael J, Hiebert SW. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F. Oncogene 10: 405-415, 1995.
8. Jeon IS, Davis JN, Braun BS, Sublett JE, Roussel MF, Denny CT, Shapiro DN. A variant Ewing's sarcoma translocation (7; 22) fuses the ews gene to the ets gene etv1. Oncogene: 10: 1229-1234, 1995.
9. Davis JN and Roussel MF. Molecular cloning and expression of the cDNA for murine Elf-1. Gene: 171:265-269, 1996.
10. Ernst P, Hahm K, Trinh L, Davis JN, Roussel MF, Turck CW, Smale ST. A potential role for Elf-1 in terminal transferase gene regulation. Mol Cell Biol 16: 6121-6131, 1996.
11. Hiebert SW, Sun W, Davis JN, Golub T, Shurtleff S, Buijs A, Downing JR, Grosveld G, Roussel MF, Gilliland DG, Lenny N, Meyers S. The t (12; 21) translocation converts AML-1B from an activator to a repressor of transcription. Mol Cell Biol 16: 1349-1355, 1996.
12. Davis JN, Rock CO, Cheng M, Ashmun RA, Kirk H, Kay R, Roussel MF. Growth factor receptor-dependent mitogenic signaling mediated by a truncated type I phosphatidylinositol-4 phosphate 5-kinase. Mol Cell Biol 17:7398-7406, 1997.
13. Davis JN, Williams BJ, Herron JT, Galiano FJ, Meyers SM. ETO-2, a new member of the ETO-family of nuclear proteins. Oncogene, 18, 1375-1383, 1999.
14. Shyng S-L, Barberi A, Gumusboga A, Cukras C, Pike L, Davis JN, Stahl PD, Nichols CG. Modulation of nucleotide sensitivity of ATP-sensitive potassium channels by phsophatidylinositol-4-phosphate 5-kinase. Proc Natl Acad Sci USA 97:937-941, 2000.
15. Buijs A, van Rompaey L, Molijn AC, Davis JN, Vertegaal AC, Potter MD, Adams C, van Baal S, Zwarthoff EC, Roussel MF, Grosveld GC. The MN1-TEL fusion protein, encoded by the translocation (12;22)(p13;q11) in myeloid leukemia, is a transcription factor with transforming activity. Mol Cell Biol. 20:9281-93, 2000.
16. Barbieri MA, Heath CM, Peters EM, Wells A, Davis JN, and Stahl PD. Phosphatidylinositol -4-phosphate-5-kinase-1b is essential for EGF-receptor mediated endocytosis. J Biol Chem 276:, 2001.
17. Galiano FJ, Ulug ET, and Davis JN. Overexpression of murine phosphatidylinositol 4-phosphate 5-kinase disrupts a phosphatidylinositol 4,5 bisphosphate regulated endosomal pathway. J Cell Biochem. 85:131-145, 2002.
|